{"id":18338,"date":"2019-12-13T22:34:00","date_gmt":"2019-12-13T22:34:00","guid":{"rendered":"http:\/\/eurojournalists.com\/?guid=9ae253129a2ee60d2cd1cecc96586f49"},"modified":"2019-12-13T22:34:00","modified_gmt":"2019-12-13T22:34:00","slug":"amarin-gets-fda-approval-for-new-vascepa-use-u-s-shares-gain-in-late-trading-marketwatch","status":"publish","type":"post","link":"https:\/\/eurojournalists.com\/?p=18338","title":{"rendered":"Amarin gets FDA approval for new Vascepa use, U.S. shares gain in late trading &#8211; MarketWatch"},"content":{"rendered":"<ol>\n<li><a href=\"https:\/\/news.google.com\/__i\/rss\/rd\/articles\/CBMicWh0dHBzOi8vd3d3Lm1hcmtldHdhdGNoLmNvbS9zdG9yeS9hbWFyaW4tZ2V0cy1mZGEtYXBwcm92YWwtZm9yLW5ldy12YXNjZXBhLXVzZS11cy1zaGFyZXMtcmVtYWluLWhhbHRlZC0yMDE5LTEyLTEz0gFPaHR0cHM6Ly93d3cubWFya2V0d2F0Y2guY29tL2FtcC9zdG9yeS9ndWlkL0JDMDg3MzQ3LTAyNjAtNDQwNC05MDdELUYxMEY2QTY4NTFCMw?oc=5\" >Amarin gets FDA approval for new Vascepa use, U.S. shares gain in late trading<\/a>&nbsp;&nbsp;<font color=\"#6f6f6f\">MarketWatch<\/font><\/li>\n<li><a href=\"https:\/\/news.google.com\/__i\/rss\/rd\/articles\/CBMiSmh0dHBzOi8vd3d3LnlhaG9vLmNvbS9saWZlc3R5bGUvZmRhLWFwcHJvdmVzLWZpcnN0LWZpc2gtb2lsLTIyMzU1MTQxNi5odG1s0gFSaHR0cHM6Ly93d3cueWFob28uY29tL2FtcGh0bWwvbGlmZXN0eWxlL2ZkYS1hcHByb3Zlcy1maXJzdC1maXNoLW9pbC0yMjM1NTE0MTYuaHRtbA?oc=5\" >US approves fish oil-based drug for cutting heart risks<\/a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Yahoo Lifestyle<\/font><\/li>\n<li><a href=\"https:\/\/news.google.com\/__i\/rss\/rd\/articles\/CBMiYGh0dHBzOi8vd3d3LmludmVzdG9ycy5jb20vbmV3cy90ZWNobm9sb2d5L2FtYXJpbi1zdG9jay1mZGEtYXBwcm92ZXMtdmFzY2VwYS1jYXJkaW92YXNjdWxhci1yaXNrL9IBAA?oc=5\" >Amarin Stock Remains Halted After FDA Approves Vascepa In Cardiovascular Risk<\/a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Investor&#8217;s Business Daily<\/font><\/li>\n<li><a href=\"https:\/\/news.google.com\/__i\/rss\/rd\/articles\/CBMia2h0dHBzOi8vd3d3Lm5iY25ld3MuY29tL2hlYWx0aC9oZWFydC1oZWFsdGgvZmRhLWFwcHJvdmVzLWZpcnN0LWZpc2gtb2lsLWRydWctY3V0dGluZy1jYXJkaWFjLXJpc2tzLW4xMTAyMDI20gEsaHR0cHM6Ly93d3cubmJjbmV3cy5jb20vbmV3cy9hbXAvbmNuYTExMDIwMjY?oc=5\" >FDA approves first fish-oil drug for cutting cardiac risks<\/a>&nbsp;&nbsp;<font color=\"#6f6f6f\">NBCNews.com<\/font><\/li>\n<li><a href=\"https:\/\/news.google.com\/__i\/rss\/rd\/articles\/CBMidGh0dHBzOi8vd3d3Lndzai5jb20vYXJ0aWNsZXMvZmRhLWFwcHJvdmVzLWZpc2gtb2lsLWRlcml2ZWQtZHJ1Zy1mb3ItdXNlLXByZXZlbnRpbmctaGVhcnQtYXR0YWNrcy1zdHJva2VzLTExNTc2Mjc3Mjk10gEA?oc=5\" >FDA Approves Fish-Oil-Derived Drug for Use Preventing Heart Attacks, Strokes<\/a>&nbsp;&nbsp;<font color=\"#6f6f6f\">The Wall Street Journal<\/font><\/li>\n<li><strong><a href=\"https:\/\/news.google.com\/stories\/CAAqOQgKIjNDQklTSURvSmMzUnZjbmt0TXpZd1NoTUtFUWkwXzdYVmpvQU1FWHFRTzdweXN0ZXpLQUFQAQ?oc=5\" >View full coverage on Google News<\/a><\/strong><\/li>\n<\/ol>\n","protected":false},"excerpt":{"rendered":"<p>Amarin gets FDA approval for new Vascepa use, U.S. shares gain in late trading&nbsp;&nbsp;MarketWatchUS approves fish oil-based drug for cutting heart risks&nbsp;&nbsp;Yahoo LifestyleAmarin Stock Remains Halted After FDA Approves Vascepa In Cardiovascu&#8230;<\/p>\n","protected":false},"author":3,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-18338","post","type-post","status-publish","format-standard","hentry"],"aioseo_notices":[],"_links":{"self":[{"href":"https:\/\/eurojournalists.com\/index.php?rest_route=\/wp\/v2\/posts\/18338","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/eurojournalists.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/eurojournalists.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/eurojournalists.com\/index.php?rest_route=\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/eurojournalists.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=18338"}],"version-history":[{"count":1,"href":"https:\/\/eurojournalists.com\/index.php?rest_route=\/wp\/v2\/posts\/18338\/revisions"}],"predecessor-version":[{"id":18339,"href":"https:\/\/eurojournalists.com\/index.php?rest_route=\/wp\/v2\/posts\/18338\/revisions\/18339"}],"wp:attachment":[{"href":"https:\/\/eurojournalists.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=18338"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/eurojournalists.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=18338"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/eurojournalists.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=18338"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}